UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data

Arthritis research & therapy, 2019-05, Vol.21 (1), p.111-11, Article 111

2019

Volltextzugriff (PDF)

Treatment recommendations for psoriatic arthritis

Annals of the Rheumatic Diseases, 2009-09, Vol.68 (9), p.1387-1394

2009

Volltextzugriff (PDF)

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.39-47

2014

Volltextzugriff (PDF)

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Annals of the rheumatic diseases, 2009-05, Vol.68 (5), p.702-709

2009

Volltextzugriff (PDF)

Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors

Annals of the Rheumatic Diseases, 2002-04, Vol.61 (4), p.298-304

Mease, P J

2002

Volltextzugriff (PDF)

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.922-929

2009

Volltextzugriff (PDF)

Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors

Annals of the rheumatic diseases, 2006-10, Vol.65 (10), p.1373-1378

2006

Volltextzugriff (PDF)

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

Annals of the rheumatic diseases, 2005-11, Vol.64 (suppl 4), p.iv2-iv14

2005

Volltextzugriff (PDF)

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

The Lancet (British edition), 2000-07, Vol.356 (9227), p.385-390

2000

Volltextzugriff (PDF)

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial

Arthritis & rheumatology (Hoboken, N.J.), 2012-02, Vol.64 (2), p.360-370

2012

Volltextzugriff (PDF)

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial

Annals of the rheumatic diseases, 2007-04, Vol.66 (4), p.498-505

2007

Volltextzugriff (PDF)

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

Annals of the rheumatic diseases, 2007-02, Vol.66 (2), p.163-168

2007

Volltextzugriff (PDF)

Axial Spondyloarthritis

1, 2019

Volltextzugriff (PDF)

Psoriatic arthritis assessment tools in clinical trials

Annals of the rheumatic diseases, 2005-03, Vol.64 (suppl 2), p.ii49-ii54

2005

Volltextzugriff (PDF)

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.48-55

2014

Volltextzugriff (PDF)

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group

Clinical rheumatology, 2017-01, Vol.36 (1), p.15-24

2017

Volltextzugriff (PDF)

Psoriatic arthritis: update on pathophysiology, assessment and management

Annals of the rheumatic diseases, 2011-03, Vol.70 (Suppl 1), p.i77-i84

Mease, Philip J

2011

Volltextzugriff (PDF)

The potential roles for novel biomarkers in rheumatoid arthritis assessment

Clinical and experimental rheumatology, 2011-05, Vol.29 (3), p.567

Mease, P J

2011

Volltextzugriff (PDF)

Psoriatic arthritis and imaging

Annals of the rheumatic diseases, 2005-03, Vol.64 (suppl 2), p.ii55-ii57

2005

Volltextzugriff (PDF)

Psoriatic arthritis treatment: biological response modifiers

Annals of the rheumatic diseases, 2005-03, Vol.64 (suppl 2), p.ii78-ii82

2005

Volltextzugriff (PDF)

The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up

British journal of dermatology (1951), 2021-11, Vol.185 (5), p.935-944

2021

Volltextzugriff (PDF)

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial

Annals of internal medicine, 1999-03, Vol.130 (6), p.478

1999

Volltextzugriff (PDF)

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004

Annals of the rheumatic diseases, 2004-11, Vol.63 (suppl 2), p.ii2-ii12

2004

Volltextzugriff (PDF)

Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry

Journal of the European Academy of Dermatology and Venereology, 2019-05, Vol.33 (5), p.886-892

2019

Volltextzugriff (PDF)

Seronegative spondyloarthropathies: to lump or split?

Annals of the rheumatic diseases, 2005-03, Vol.64 (suppl 2), p.ii9-ii13

2005

Volltextzugriff (PDF)

1 – 25 von 633

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(575)
Mit Volltextzugriff
(348)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(209)
Life Sciences & Biomedicine
(206)
Humans
(189)
Psoriatic Arthritis
(189)
Rheumatology
(184)
Patients
(130)
Psoriasis
(114)
Arthritis
(112)
Male
(99)
Female
(94)
Biological And Medical Sciences
(93)
Medical Sciences
(93)
Treatment Outcome
(86)
Middle Aged
(84)
Clinical Trials
(83)
Adult
(75)
Diseases Of The Osteoarticular System
(73)
Pain
(70)
Arthritis, Psoriatic - Drug Therapy
(62)
Double-Blind Method
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(18)

Menü

Weitere Dienste

Einstellungen

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data

Treatment recommendations for psoriatic arthritis

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial

Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty-eight-week randomized, double-blind, placebo-controlled, parallel-group phase III trial

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

Axial Spondyloarthritis

Psoriatic arthritis assessment tools in clinical trials

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group

Psoriatic arthritis: update on pathophysiology, assessment and management

The potential roles for novel biomarkers in rheumatoid arthritis assessment

Psoriatic arthritis and imaging

Psoriatic arthritis treatment: biological response modifiers

The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial

Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004

Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry

Seronegative spondyloarthropathies: to lump or split?

Suchergebnisse filtern